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Summary
 
We studied the role of bone marrow B cell production in the renewal of peripheral B cells and
the feedback mechanisms that control the entry of newly formed B cells into the peripheral B
cell pools. When resting lymph node B cells are injected into B cell–deficient hosts, a fraction
of the transferred cells expands and constitutes a highly selected population that survives for
prolonged periods of time by continuous cell renewal at the periphery. Although the number
of donor B cells recovered is low, a significant fraction shows an activated phenotype, and the
serum immunoglobulin (Ig)M levels are as in normal mice. This population of activated B cells
is resistant to replacement by a new cohort of B cells and is able to feedback regulate both the
entry of newly formed B cells into the peripheral pool and terminal differentiation. These find-
ings suggest that peripheral B cell selection follows the first come, first served rule and that
IgM-secreting cells are generated from a pool of stable activated B cells with an independent
homeostasis. 
Key words: homeostasis • B cell renewal • lymphocyte competition • B cell lifespans • natural 
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I
 
n adult mice, the presence of a homeostatic control of B
cell numbers implies a kinetic steady state where cell
production equals cell loss (1). According to current esti-
mates, the rate of B cell production (1–2 
 
3
 
 10
 
7
 
 B cells gen-
erated daily) could replenish the peripheral B cell pool in
5–10 d (2–6). It was also shown that the number of periph-
eral B cells is not limited by the rate of B cell production in
the bone marrow (BM)
 
1
 
 (7, 8); mice with a threefold re-
duced BM B cell production still had normal numbers of
peripheral B cells and the B cell production of one mouse
sufficed to replenish the peripheral B cell pools of three
mice (7). In an immune system where there is a continuous
excess of B cell production and the total number of B cells
is kept constant, each newly produced B cell can only es-
tablish itself upon loss of other cells (9), i.e., the rate of pe-
ripheral B cell renewal depends on the life span of periph-
eral B cells. However, the life expectancy of a B
lymphocyte is not an intrinsic property of the cell, but is
determined by the environment (10) and by the presence
or absence of other competing cell populations (9, 11).
Therefore, the persistence of B cells at the periphery could
be modified by the continuous arrival of the newly formed
BM migrants, while the fate of the latter at the periphery
could also be altered by the presence or absence of resident
B cell populations.
In this study, we investigated the possible mutual influ-
ences between established resident populations of periph-
eral B cells and newly formed B cell migrants. The ques-
tions addressed by these studies are: What is the role of B
cell production in peripheral B cell renewal? Are there
feedback mechanisms that control new B cell entry into the
peripheral B cell pools? To answer these questions we
compared (a) the persistence of peripheral B cells in the
presence or absence of new BM B cell production; for this
purpose we studied the fate of mature resting B cells trans-
ferred alone or simultaneously with a pool of precursor
cells into immunodeficient mice (Rag2
 
2
 
/
 
2
 
); and (b) the
fate of a population of B cells (recent BM migrants or ma-
ture B cells) in the presence of a previously established pe-
ripheral B cell population; in this case we followed the
seeding and the persistence of a second population of B
cells in B cell–deficient mice previously injected with a co-
hort of mature B cells.
These studies provide a novel insight into the origin of
IgM-secreting cells and serum IgMs, and into the indepen-
dent homeostatic control of resting and activated peripheral
 
1
 
Abbreviations used in this paper:
 
 BM, bone marrow; BrdU, bromodeoxy-
uridine; LN, lymph node; SPL, spleen; Tg, transgenic. 
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B cell pools. They also contribute to our understanding of
B cell physiology during peripheral lymphocyte reconstitu-
tion of immunodeficient hosts.
 
Materials and Methods
 
Mice.
 
The inbred strains of mice C57Bl/6 (IgH
 
b
 
, Ly5
 
2
 
), Ly5
congenic C57Bl/6 (IgH
 
b
 
, Ly5
 
1
 
), IgH congenic C57Bl/6 (IgH
 
a
 
,
Ly5
 
2
 
), SP6 transgenic (Tg) C57Bl/6 (transgene IgM
 
a
 
, Ly5
 
2
 
) (12),
MD4 Tg C57Bl/6 (transgene IgM
 
a
 
, Ly5
 
2
 
) (13), B cell–deficient
IgM homologous recombinant mutant 
 
m
 
MT C57Bl/6 (Ig
 
2
 
,
Ly5
 
2
 
) (14), the alymphopenic Rag2-deficient mutant Rag2
 
2
 
/
 
2
 
C57Bl/6 (Ig
 
2
 
, Ly5
 
2
 
) (15), the T cell–deficient CD3 homologous
recombinant mutant CD3
 
e
 
2
 
/
 
2
 
 C57Bl/6 (IgH
 
b
 
, Ly5
 
2
 
) (16), and
the B6-E
 
m
 
-bcl-2-22 Tgs (17) were obtained from Iffa-Credo and
the Centre de Développement des Techniques Avancées, Centre
National de la Recherche Scientifique, France.
 
Cell Transfers.
 
Sterile suspensions of pooled mesenteric and in-
guinal lymph nodes (LN) collected free of blood were prepared.
Host 8-wk-old Rag2
 
2
 
/
 
2
 
 mice were exposed to irradiation given by
a Cesium source. A 300 rad dose of irradiation was given to the an-
imals when they were reconstituted with a single injection of LN
cells. The irradiation dose was increased up to 900 rad when BM
cells were added to the inoculum, to allow seeding of the precursor
cells. In this case Rag2
 
2
 
/
 
2
 
 and 
 
m
 
MT hosts were used indifferently
with similar results. In experiments involving sequential injections
(two injections of LN suspensions separated by a time interval of
4 wk) the recipient mice (in this case only Rag2
 
2
 
/
 
2
 
 were used)
were not irradiated. We must note that the dose of irradiation did
not modify the fate of transferred mature B cells. A total of 
 
z
 
1–2 
 
3
 
10
 
7
 
 LN cells and/or 10
 
6
 
 BM cells were injected intravenously
(retro-orbital vein) into the immunodeficient hosts. Injected popu-
lations differ by allotypic markers (Ly5
 
1
 
 
 
or
 
 
 
2
 
 or IgH
 
a
 
 
 
or
 
 
 
b
 
 allotype).
 
Flow Cytometry Analysis.
 
The following mAbs were used:
anti-Ly5
 
1
 
 (A20), anti-Ly5
 
2
 
 (104.2), anti-B220 (RA3-6B2), anti-
IgM (R6-60.2), anti-IgM
 
a
 
 (RS3.1), anti-IgM
 
b
 
 (MB86), anti-
HSA (J11d or M1/69), anti-IgD, anti-CD23 (B3B4), anti-Mel14
(CD62L), anti-CD5 (53-7.3), and anti-CD21 (7G6). Cells were
triple stained with appropriate combinations of FITC-, PE-, and
biotin-labeled antibodies, followed by streptavidin TRI-Color
(Caltag). Dead cells were excluded from the analysis by light-
scatter and/or propidium iodide. All analyses were performed on
a FACScan
 
®
 
 (Becton Dickinson) interfaced to a Macintosh com-
puter with the Becton Dickinson Cell Quest software.
 
Quantification of B Cell Subpopulations in the Host Mice.
 
Re-
cipient mice were killed at different times after transfer. A stan-
dard procedure was used to prepare single cell suspensions from
spleen (SPL), BM, and a pool of mesenteric and inguinal LN.
The total number of B cells present in each organ was calculated
from the frequency estimated by immunofluorescence analysis
and the total number of cells recovered in each organ.
 
BrdU Labeling.
 
Mouse chimeras received 1 mg of BrdU intra-
peritoneally every 4 h the day before killing (four injections). SPL
cells from BrdU injected mice were triple stained with PI and the
appropriate anti-B220 and anti-IgM antibody combinations. The
B220
 
1
 
IgM
 
1
 
 labeled B cells sorted using a FACStar
 
1
 
®
 
 (Becton
Dickinson). Purified populations were fixed, their DNA dena-
tured and labeled with a mouse 
 
g
 
1 anti-BrdU monoclonal (a gift
of Dr. T. Ternynck, Institut Pasteur, Paris, France) followed by a
FITC-labeled goat anti–mouse 
 
g
 
1 Ab (Southern Biotechnology
Associates). The fraction of BrdU
 
1
 
 cells in each purified B cell
population was evaluated on a FACScan
 
®
 
.
 
ELISA.
 
Sera Ig concentrations were quantified by ELISA.
Plates were coated either with antibodies to total IgM, IgM
 
a
 
, or
IgM
 
b
 
 and saturated with PBS-1% gelatin. Dilutions of sera were
added. After incubation (1 h, 37
 
8
 
C) and washing, peroxidase-
labeled goat anti–mouse IgM antibodies were added. After incu-
bation and washing, bound antibodies were revealed with the
substrate 
 
O
 
-phenylenediamine and H
 
2
 
O
 
2
 
. The reaction was
stopped after 10 min by addition of 10% SDS and the absorbance
read at 450 nm in a Titertek Multiscan Spectrometer (Flow Lab-
oratories). Titration of serum IgM was performed using as stan-
dards purified mouse IgM (Southern Biotechnology, Inc.). IgM
concentrations were determined by comparing the displacement
of the dilution curves in the linear interval between standards at a
concentration of 10 
 
m
 
g/ml and the serum samples.
 
ELISA Spot Assay.
 
The quantification of IgM secreting cells
was assayed by a modification of the Sedgwick and Holt ELISA
Spot Assay technique (7). In brief, plates were coated with goat
anti–mouse IgM antibodies or antiallotypic IgM antibodies. After
saturating, the cells were distributed into the microwells in
RPMI 1640–2% FCS. The plates were incubated for 4–6 h at
37
 
8
 
C, 5% CO
 
2
 
 atmosphere. After an extensive wash, plates were
incubated with goat anti–mouse IgM labeled with alkaline phos-
phatase. After washing, the revealing substrate was added (2.3
mM 5-bromo-4-chloro-3-indolyl phosphate diluted in 2-amino-
2-methyl-1-proprenolol buffer).
 
RT-PCR.
 
Populations of LN-derived total (B220
 
1
 
IgM
 
1
 
),
SPL resting (IgM
 
low
 
IgD
 
high
 
), or SPL activated B cells (IgM
 
high
 
IgD
 
low
 
) were purified by cell sorting after staining with the appro-
priate antibody combinations. Total RNA was isolated from the
sorted B cells (
 
.
 
99% pure). RNA was reverse transcribed into
cDNA. The primers used for the detection of HPRT, IL-2, IL-4,
IL-6, IL-10, IL-12, and IFN-
 
g
 
 cDNA were as described previ-
ously (18). The 40 cycles of amplification were: 10 s at 94
 
8
 
C, 30 s
at 60
 
8
 
C, 30 s at 72
 
8
 
C, followed by 10 min of elongation at 72
 
8
 
C.
Samples were separated in 2% agarose gels and stained with ethid-
ium bromide.
 
Results
 
Fate of Resting LN B Cells Transferred into Immunodeficient
Host Mice in the Absence of BM B Cell Production.
 
To study
the fate of a peripheral population of resting B cells in ab-
sence of de novo BM B cell production, we transferred 10
 
7
 
LN cells from B6.Ly5
 
1
 
 donors into 300 rad irradiated B cell–
deficient B6.Ly5
 
2
 
 hosts (B6.Rag2
 
2
 
/
 
2
 
). These LN B cells
are highly enriched for IgM
 
low
 
IgD
 
high
 
 small resting cells
(
 
.
 
98%) which were HSA
 
low
 
, CD21
 
int
 
, CD23
 
bright
 
, Mel14
(CD62L)
 
bright
 
, CD44
 
int
 
, CD5
 
2
 
, and CD69
 
2
 
 (see below and
data not shown). The transferred cell cohort lacked hema-
topoietic precursors, as their injection into lethally irradi-
ated (900 rad) mice failed to rescue these recipient mice,
which all died between days 10 and 14 after transfer.
We quantified the number of donor LN B cells recov-
ered from the spleen of the host mice during the 16-wk
period after transfer (Fig. 1 A and data not shown). Soon
after injection and homing the number of donor B cells de-
creased: of the 4–5 
 
3
 
 10
 
6
 
 B cells transferred only 10
 
5
 
 B
lymphocytes survived at day 2. From day 2 onwards the
number of donor B cells increased to reach a maximum of
1–2 
 
3
 
 10
 
6
 
 by day 14, corresponding to 
 
z
 
30% of the num-
ber of B cells injected. This increase in donor B cell num- 
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bers was due to the peripheral expansion of donor cells,
since after a 24-h pulse of BrdU, given at day 5 after trans-
fer, a significant fraction of the donor B cells was cycling
(20% of the B cells were BrdU
 
1
 
) (Table I).
The population of donor B cells recovered at 2 wk after
injection was able to persist at constant numbers up to 4 mo.
A significant fraction of these cells incorporated BrdU (Ta-
ble I), suggesting that self-renewal contributed to their pro-
longed survival. In spite of the continuous division, trans-
ferred B cells were unable to reconstitute normal peripheral
B cell numbers.
When the B cell populations recovered 1 mo after trans-
fer were characterized, a significant fraction of these B cells
exhibited an activated phenotype (19); their size was in-
Figure 1. (A) Fate of LN B cells transferred into immunodeficient Rag22/2
mice. Each host mouse was injected with 107 cells (4 3 106 B cells). Each
point represents the number of donor LN-derived B cells (B2201 m1) re-
covered in the SPL of three to six host mice as a function of time. The curve
joins the mean of the values obtained at each time point. (B) Phenotype of in
vivo activated B cells. Rag22/2 mice were injected with 4 3 107 LN cells
(1.8 3 107 B cells). The hosts were killed 2 mo later and the SPL cells ana-
lyzed by flow cytometry. Histograms are gated for the B2201 B cell popula-
tion. Bold line, phenotypic analysis of LN-derived B cells. Thin line, pheno-
typic analysis of splenic B cells from C57Bl/6 control mice. (C) Contour plot
showing the sorted B2 cells from CD3e2/2 donors before and after in vivo ac-
tivation in Rag22/2 hosts. Similar observations were made when LN cells
from the same donors were transferred. (D) Cytokine profile of in vivo acti-
vated B cells. RT-PCR was performed on sorted B cells (.99% pure). Lanes
from the left to the right: splenic cells from Rag22/2 mice injected 1 mo be-
fore with LN cells from CD3e2/2 donors (pool of 10 mice); mature B cells
(IgMlowIgDhigh) from the SPL of CD3e2/2 mice (pool of 5 mice); activated B
cells (IgMhighIgDlow) from the SPL of CD3e2/2 mice (pool of 5 mice); B cells
from the LN of CD3e2/2 mice (pool of 5 mice). (E) Number of IgM-
secreting cells in the SPL of immunodeficient hosts injected with 107 cells (4 3 106 B cells) as a function of time. Each point represents one individual
mouse and the curve joins the mean values obtained in each time point.322 Homeostasis of Activated B Cells
creased, they were IgMbright, IgDdull, HSAbright, CD23dull,
Mel14 (CD62L)dull, CD44int, and, in contrast to recent BM
migrants, they were CD21bright (Fig. 1 B and data not
shown) (20). They did not express the CD5 marker, the
CD69 early activation marker, and they were Mac12, B7-
12, B7-22, and Syndecan2. We must note that the trans-
ferred LN B remained CD52 throughout the duration of
the kinetics. These findings suggest that a fraction of the
donor B cells differentiates from a resting to an activated
phenotype or that rare activated cells present in the cell in-
oculum can expand substantially after in vivo transfer. This
latter possibility is unlikely since 2 mo after transfer of
highly purified splenic IgMdullIgDbright B cells from CD3e2/2
donors into Rag22/2 mice again, we recovered predomi-
nantly cells bearing an activated phenotype (Fig. 1 C).
The interleukin mRNA expression of B2201IgM1
sorted LN CD3e2/2 donor B cells before and 2 mo after in
vivo transfer, and of resting (IgMlowIgDhigh) and activated
B cells (IgMhighIgDlow) sorted from the SPL of normal
CD3e2/2 mice was studied. As shown in Fig. 1 D, all B cell
populations transcribed IFN-g and IL-12 mRNA, but we
could not detect IL-2 or IL-4 mRNA transcription. Trans-
ferred B cells, as well as sorted activated splenic B cells,
were unique in their transcription of IL-10 and IL-6
mRNA (Fig. 1 D).
We studied the splenic IgM-secreting cells and serum
IgM levels of the immunodeficient mice hosting transferred
B cells. We found that by 2 wk after injection, the number
of IgM-secreting cells (z3 3 105) (Fig. 1 E) as well as the
serum IgM levels (200–250 mg/ml) in transferred hosts
reached the normal levels found in a B6 mouse. Whereas
IgM-secreting cells in normal mice generally represent
z0.2–0.6% of the total number of splenic B cells, in in-
jected immunodeficient hosts the IgM-secreting cells rep-
resent 7–30% of all splenic B cells. This finding confirms
previous observations about the presence of normal num-
bers of activated IgM-secreting B cells and serum IgM lev-
els in mice with reduced peripheral B cell numbers (7, 21).
We conclude that, after transfer, donor B cells were rapidly
activated to establish the normal number of plasmocytes
and serum levels of IgM. The results reported were ob-
tained regardless of the presence of T cells or when do-
nor and host mice were devoid of T cells, i.e., when
B6.Rag22/2 were injected with resting B cells from CD3e2/2
mice (see results shown in Fig. 1, C and D). We concluded
that the full reconstitution of the persistent activated IgM-
secreting B cell compartment is T cell independent.
Fate of B Cells as a Function of the Number of Lymphocytes
Injected. Immunodeficient mice were injected with vary-
ing numbers of LN B cells (from 0.1 to 40 3 106) and the
number and phenotype of the B cells recovered in different
host tissues studied 2 mo after transfer. Comparing different
groups of hosts, we observed that in mice injected with 106
and 30 3 106 cells (a 30-fold difference) the difference in
the number of B cells recovered 4 mo after transfer was
only sixfold, suggesting that after the initial burst of expan-
sion, the transferred B cells tend to slowly reach a stable
equilibrium number (Fig. 2 A). Independent of the initial
number of B cells transferred, the number of IgM-secreting
cells recovered in all recipient mice was identical and simi-
lar to the physiological number of IgM-secreting cells of
normal C57Bl/6 (B6) mice (Fig. 2 B).
Studying the homing of the transferred cells, we found
that in mice injected with ,106 B cells we were not able to
recover any donor B cells outside the host SPL (Fig. 2 C).
The vast majority of splenic donor–derived cells showed an
activated IgMbrightIgDdull phenotype. With the transfer of
progressively higher numbers of B cells, we recovered a
similar number of B cells bearing an activated phenotype
which localized mainly in the host SPL as well as increasing
numbers of resting B cells that accumulate first in the SPL
and subsequently in the LN and BM (Fig. 2, C and D).
Donor B cells were not detected in the peritoneal cavity of
the different chimeras. These results suggest that when low
numbers of B cells are available there is a preferential gen-
eration of cells with an activated phenotype that ensures
normal levels of IgM antibodies. Only after replenishment
of the activated B cell compartment do resting B cells accu-
mulate at the periphery.
Replacement of Transferred Peripheral B Cells by a Second
Population of LN B Cells: Feedback Regulation of Terminal Dif-
ferentiation of the Second B Cell Population. We showed that
after transfer into immunodeficient hosts and in absence of
other B cell populations, a fraction of the injected mature
resting B cells persists at the periphery. To study whether
the survival of these B cells was modified by presence of
other B lymphocyte populations, Rag22/2 recipients were
injected with 2 3 107 Ly51 IgHa LN B cells alone, or coin-
jected with the same number of Ly52 IgHb LN B cells 28 d
later. The fate of the different donor B cell populations in
host mice was followed for 2 mo.
We found that the fate of the first donor B cell popula-
tion was not modified by: the injection of a second inocu-
lum; the total number of the B cells recovered (Table II);
the fraction of these cells bearing an activated phenotype,
or the fact that the total number of IgM plasma cells and
the serum IgM secreted by the first donor cell population
Table I. Fraction of BrdU-labeled B Cells in Normal and 
Immunodeficient Hosts
% BrdU1 B cells
LN-derived B cells at day 6 19.0 6 4.0
LN-derived B cells at day 30 5.8 6 1.7
B cells from normal C57Bl/6 mice 1.4 6 0.2
BrdU staining of sorted SPL cells from C57Bl/6 control mice and from
immunodeficient chimeras injected with LN cells. Each mouse was in-
jected with 4 i.p. injections of 1 mg of BrdU. The day after, the mice
were killed, the SPL B2201m1 cells sorted, and BrdU1 cells identified
as described in the Materials and Methods section (mean 6 SD of three
to five mice). Chimeras were injected with 107 total LN cells and killed
either 6 d (phase of exponential growth) or 4 wk (steady state) after
transfer.323 Agenès and Freitas
remained the same after the transfer of a second B cell pop-
ulation (not shown). With respect to the second popula-
tion, a fraction of these new B cells survived in host mice,
adding to the numbers of the first B cells already present in
the host (Table II). The kinetics and cell recovery of this
second population was not affected by the presence of a
first B cell population (not shown). However, the majority
of the persisting new B cells retained a resting phenotype.
Thus, in host mice injected sequentially with two sets of
resting LN B cells we found that the majority of the acti-
vated B cells (Fig. 3 A) and most of the serum IgMs
(.80%) are derived from the first group of B cells. Directly
comparing the amount of IgM produced by the same B
cells transferred alone or into mice hosting an established
population of B cells, we found that the level of serum IgM
produced by the second B cell population was diminished
(Fig. 3 B). These findings suggest that once the compart-
ment of peripheral activated B cells is replenished and nor-
mal serum IgM levels are attained, there exists a feedback
mechanism which inhibits the differentiation and IgM se-
cretion of a second population of transferred B cells. How-
ever, this feedback regulation did not prevent in these
experimental conditions the accumulation of the newly in-
jected B cells in a resting state.
Replacement of Transferred Peripheral B Cells by a Second
Population of BM-derived B Cells in Immunodeficient Hosts.
Next we studied the possible mutual influences between a
resident B cell population and BM newly formed B cell mi-
grants. For this purpose, 107 LN cells and 106 BM cells were
coinjected intravenously into 900 rad irradiated immuno-
deficient host mice (B6mMT or B6.Rag22/2). Using this
approach, we allow the establishment of a peripheral B cell
Figure 2. (A) Number of B cells recovered in the SPL of immunodeficient Rag22/2 mice as a function of time. Each curve corresponds to a group of
mice (three to six individuals) injected with a particular number of cells: u, 106 LN cells (0.3 3 106 B); e, 5 3 106 LN cells (1.5 3 106 B cells); s, 10 3
106 LN cells (3 3 106 B cells); and n, 30 3 106 LN cells (9 3 106 B cells). (B) Number of IgM-secreting cells recovered in the SPL of immunodeficient
mice as a function of time. Each curve corresponds to a group of mice (three to six individuals) injected with a particular number of cells: u, 106 LN cells
(0.3 3 106 B cells); e, 5 3 106 LN cells (1.5 3 106 B cells); s, 10 3 106 LN cells (3 3 106 B cells); n, 30 3 106 LN cells (9 3 106 B cells). (C) Number
of B cells recovered in the SPL (s), the LN (n), and the BM (e) as a function of the number of LN B cells injected into immunodeficient mice two mo
after transfer (mean 6 SD of three to six mice). (D) Phenotype of B cells recovered in the BM, SPL, and LN of the same immunodeficient mouse recon-
stituted with 4 3 107 LN B cells. In the SPL the majority of B cells show an activated phenotype (IgMhighIgDlow), whereas resting B cells (IgMlowIgDhigh)
accumulate in the SPL, LN, and BM.324 Homeostasis of Activated B Cells
population which occurs 2 wk after mature LN B cell trans-
fer (Fig. 1), i.e., before the appearance of newly formed
BM-derived cell migrants. Therefore B lymphocytes of BM
origin enter a peripheral compartment which is already
seeded with activated LN-derived B cells. Since irradiation
of the hosts was required to allow BM reconstitution, we
first studied the fate of LN B cells in lethally irradiated hosts
coinjected with BM cells from mMT donors (unable to gen-
erate B cells). We found that the kinetics of recovery of the
transferred LN B cell population was identical to that de-
scribed in nonirradiated or 300 rad irradiated mice reconsti-
tuted with LN B cells alone (see Fig. 1 A). Thus, the fate of
the transferred B cells was independent of host irradiation.
We compared the fate of the different B cell populations
in mice coinjected with LN B cells and BM cells from im-
munocompetent donors. In these mice, the total number of
B cells of LN origin was comparable to those recovered in
absence of BM derived B cells, i.e., was unchanged by the
continuous BM B cell generation and B cell output (Fig. 4
and Table III). The rate of reconstitution of peripheral B
cell numbers by the BM-derived B cells was also similar in
mice reconstituted with BM alone or mixtures of LN and
BM cells. In contrast to the population of persisting LN-
derived B cells the vast majority of the BM-derived B cells
showed a resting IgMdullIgDbright phenotype (not shown).
From 2 wk onwards the number of BM-derived B cells
present at the periphery was 10–100 times higher than the
number of LN-derived B cells (Fig. 4).
The total serum IgM concentrations were similar to
those in normal mice. The number of IgM-secreting cells
of BM origin represented ,1% of the total number of BM-
derived B cells, whereas the number of IgM-secreting B
cells of LN origin was z6% of the number of LN-derived
B cells. However, the levels of IgM of LN origin were di-
minished compared to mice injected with LN B cells alone,
suggesting that a small fraction of the LN-derived IgM-
secreting cells had been successfully replaced from the bulk
of BM-derived cells in excess.
We conclude that a fraction of the LN-derived B cells
upon activation can persist as a stable self-renewing popula-
tion which is only very slowly replaced by newly formed B
cells generated in the BM. In the presence of this resident
activated population newly produced BM B cells accumu-
late to fully reconstitute the physiological size of the resting
B cell pool.
Increased Peripheral B Cell Survival Modifies the Rate of En-
try of Newly Formed B Cells from the BM into the Peripheral
Pool. Constitutive expression of the protein encoded by
the protooncogene bcl-2 can enhance the survival of both
immature and mature B cells (17, 22). To investigate
whether an increased cell survival and accumulation of B
cells at the periphery could modify the persistence of the
transferred LN populations or the rate of entry of new BM
B cell migrants we used cells from control and bcl-2 Tg
donors to reconstitute immunodeficient host mice.
Table II. Number of B Cells Recovered in the Spleen of Mice 
Injected with One or Two LN Cell Populations
Number of LN B cells 
injected
Number of B cells recovered/
host spleen from
(3 106)( 3 106)
First 
population
(Ly52IgHa)
Second 
population
(Ly51IgHb)
First 
population
(Ly52IgHa)
Second 
population
(Ly51IgHb)
7 7 2.36 6 0.30 2.15 6 0.20
7 – 2.23 6 0.49 –
– 7 – 2.46 6 0.68
Rag22/2 mice received one or two injections of 7 3 106 LN B cells
within a time interval of 4 wk. Control mice received just one injection
of either LN population. The values represent the number of LN-derived
B cells recovered in the spleen of the different hosts 4 wk after the
transfer of the second LN population (i.e., 8 wk after the first popula-
tion). Mean 6 SD of five to seven mice per group. 
Figure 3. (A) IgM/IgD staining
on SPL B cells recovered in a
Rag22/2 mouse injected with two
LN populations sequentially.
(Top) Relative proportion of Ly51
cells in IgMlowIgDhigh subpopula-
tion (mature B cells). (Bottom)
Relative proportion of Ly51 cells
in IgMhighIgDlow subpopulation
(activated B cells). Note that acti-
vated B cells (IgMhighIgDlow) are
primarily Ly512, thus derived from
the first population injected. (B)
IgMb allotype concentrations in
mice injected with B6Ly51 LN
population (Ly51, IgHb) either
alone (s) or that also received
B6IgHa LN population (Ly52,
IgHa) 1 mo before (u). Mice were
killed 1 mo after the transfer of the
B6Ly51 LN population.325 Agenès and Freitas
We compared the persistence of the LN-derived B cells
from normal B6.Ly51 donors in chimeras simultaneously re-
ceiving BM cells from either B6 control or B6.bcl-2 Tg Ly52
donors. 2 mo after transfer we recovered an identical number
of LN-derived B cells in the two groups of host mice (Table
III, Exp. 1). This finding suggests that the established B cells
represent a highly selected population which persists even
when in the presence of newly formed B cells with an in-
creased life span.
We also injected immunodeficient mice with BM precur-
sors from normal B6.Ly51 donors and LN cells from B6.Ly52
normal or bcl-2 Tg mice. In the chimeras receiving bcl-2 Tg
cells we recovered a significantly higher number of persisting
LN-derived B cells than in mice injected with LN cells from
non-Tg donors (Table III, Exp. 2). More interestingly, we
found that in the chimeras injected with LN cells from bcl-2
Tg donors there was a modest reduction in the number of
BM-derived B cells compared to the chimeras receiving
LN cells from non-Tg mice (Table III, Exp. 2). To further
elucidate these results we performed a third experiment in
which we transferred BM precursors from double congenic
B6.Ly51IgHa donors alone or together with LN B cells from
bcl-2 Tg Ly52IgHb donors. By transferring a higher number of
LN cells (5 3 107) we were able to recover an increased num-
ber of LN-derived B cells. In this case we observed that the
reduction of the number of BM-derived B cells in the hosts
coinjected with LN cells was more marked than in the previ-
ous experiment (Table III, Exp. 3). Considering that the actual
number of resident peripheral B cells is minor (z9 3 106)
compared with the total number of BM-derived B cells these
findings may suggest that the presence of an increased number
of long-lived B cells can reduce or delay the entry of new B
cells from the BM into the peripheral B cell pools. In these lat-
ter chimeras using double congenic Ly5 and IgH B6 donors
we were also able to test the differential origin of the serum
IgMs. We found that the serum IgMb levels produced by the
LN-derived bcl2 Tg B cells were increased (518.4 6 51.8
mg/ml) compared to those in mice hosting normal B cells.
In contrast the IgMa secretion by BM-derived B cells was
considerably reduced in the presence of the LN-derived
bcl2 Tg population (IgMa serum levels of BM cells alone:
193.6 6 83.9 mg/ml; in the presence of LN cells: 9.3 6
4.8 mg/ml). We concluded that the feedback regulation ca-
pacity seems to correlate with the number and the in-
creased life span of resident peripheral B cells.
Discussion
In this study we have investigated whether the persistence
of peripheral B cells could be modified by de novo BM B
cell production and whether the entry of BM migrants
Figure 4. (A) Fate of LN-derived and BM-derived B cells in immuno-
deficient mice. Each host mouse was injected simultaneously with 4 3
106 LN B cells and 106 BM cells. Each point represents the number of do-
nor LN-derived B cells (s) and BM-derived B cells (u) recovered in the
SPL of three to six host mice as a function of time. The curves join the
mean of the values obtained at each time point for each B cell population.
Table III. Number of BM-derived and LN-derived B Cells in Chimeras Injected Simultaneously with LN and BM Cells from Different
Donor Mice
Number of B cells recovered per host spleen (3 106)
Injected cells BM-derived LN-derived
Exp. 1 LN Ly51 alone — 1.05 6 0.22
LN Ly51 1 BM Ly52 37.4 6 9.2 0.97 6 0.34
LN Ly51 1 BM Ly52.bcl2Tg 103.6 6 26.8 1.11 6 0.36
Exp. 2 LN Ly52 1 BM Ly51 50.1 6 20.5 1.56 6 0.84
LN Ly52bcl2Tg 1 BM Ly51 30.2 6 13.6 4.88 6 3.6
Exp. 3 BM Ly51.IgHa alone 49.4 6 2.6 —
LN Ly52.IgHb bcl2Tg 1 BM Ly51.IgHa 17.8 6 9.2 8.51 6 0.9
B cell–deficient Rag22/2 mice were lethally irradiated and injected simultaneously with mixtures of LN (107 in Exp. 1; 1.5 3 107 for Exp. 2, and 5 3
107 in Exp. 3) and BM cells (1–2 3 106) from different donor mice. 1 mo after reconstitution host mice were killed and the number of LN-derived
and BM-derived B cells quantified in the spleen. Each value represents the mean 6 SD of five to eight mice. In Exp. 3, where donor mice also dif-
fered by IgH allotype the IgM levels produced by either LN- or BM-derived B cells were quantified (see Results).326 Homeostasis of Activated B Cells
could be altered by the presence of a population of resident
B cells in the periphery. This novel approach could clarify
contradictory results obtained in studies on lymphocyte life
spans and renewal rates (for review see reference 23).
We studied the fate of mature LN B cells injected into
immunodeficient hosts unable to produce B cells. We
found that a fraction of the transferred population of LN B
cells expands and persists for prolonged periods of time.
These results contrast with the fate of B cells injected into
fully immunocompetent adult hosts, where it was reported
that most of the injected cells were lost shortly after transfer
(1). However, the same donor B cells persisted when trans-
ferred into newborn or 1-wk-old hosts (10). These experi-
ments confirm that B cell survival is not predetermined by
intrinsic properties of the cell but rather is dependent on
the host environment and the presence of other competitor
populations (9).
By following the kinetics of transferred B cells we found
that 48 h after the injection of a total of 4 3 106 LN B cells
we recovered only 105 donor B cells in the host SPL, i.e.,
less than the 20% predicted by homing (24). A fraction of
these cells divides extensively and at day 15 the number of B
cells recovered reaches 1–2 3 106. By extrapolation of the
exponential growth curve observed between days 2 and 10
after transfer, we estimate that the persisting B cells repre-
sent the progeny of z3–4 3 104 cells. This is z1% of the
B cells present in the initial LN inoculum. 2 wk after trans-
fer the number of B cells reached a steady state that remains
constant for at least 4 mo. An increased frequency of cy-
cling cells, as well as the continuous production of IgM-
secreting cells, suggests that the constant size of the surviving
B cell population is maintained by self-renewal. Therefore,
our findings do not support previous reports claiming the
survival of most of the naive B cells transferred into immu-
nodeficient SCID hosts (25). We show that the B cells per-
sisting after 2 wk of transfer constitute a highly selected
population which has undergone at least a 30-fold expan-
sion through five to six rounds of division and which per-
sists by continuous self-renewal in the periphery. More-
over, a significant fraction of the surviving B cells expresses
an activated phenotype and z7–30% of the cells are ac-
tively engaged in IgM secretion.
Our findings suggest that the first priority of the trans-
ferred cells is the maintenance of normal serum IgM levels
to ensure a first barrier of protection. By injecting different
numbers of B cells, we found that when low numbers of B
cells are available there is a preferential generation of acti-
vated IgM-secreting cells which localize almost exclusively
in the host’s SPL. With the transfer of increasing numbers
of B cells there is an augmented recovery of resting B cells
which accumulate progressively first in the SPL, then in the
LN and later in the BM. Serum concentrations of IgM
identical to those of control mice readily were reached in
the presence of a reduced B cell number. Resting B cells
accumulate at the periphery only when the activated B cell
compartment is complete. These results support the notion
that the homeostatic regulation of the resting and activated
B cell compartments is autonomous, indicating that the
two B cell populations belong to different immunological
niches. They may differ in survival requirements, interact
with different cell types, and follow different patterns of
homing and localization, e.g., the diminished expression of
L-selectin at the surface of the activated cells may prevent
them from homing to the LN (26). Moreover, it has been
suggested that after immunization two different subsets of
B cells would be responsible for primary (IgM unmutated
antibodies) and secondary antibody responses (mutated an-
tibodies) (27, 28). Hence it is possible that the resting B
cells generated continuously in the BM are mainly available
for immune response towards new antigens, whereas the
activated B cells may be committed to exclusively produce
natural antibodies. The ability of each subpopulation of
resting and activated B cells to respond to different antigens
is currently under study.
Once established, the population of activated B cells is
rather resistant to replacement and persists even in the pres-
ence of new emigrating cells generated from BM precur-
sors or contained in a second inoculum of LN cells. This is
not surprising considering that these activated B cells repre-
sent a highly selected population particularly adapted to the
host environment. The study of the repopulation of immu-
nodeficient hosts by transferred B cells compares the persis-
tence of two populations across the different steps of
growth, differentiation, and migration. In contrast, parabi-
osis studies the relative substitution of two preestablished
populations when mixed together. We have found that af-
ter parabiosis between B6.Ly52IgHa/B6.Ly51.IgHb con-
genic mice or between Ig-Tg (SP6 or MD4) and non-Tg
mice (B6.Ly51) the chimerism among the IgM-secreting
cells was lower than the chimerism observed among resting
B cells (Agenès, F., unpublished observations). These re-
sults suggest that resident activated B cells can more easily
persist and avoid replacement by incoming new B cells.
The selection of the persisting B cells and the production
of IgM in the immunodeficient hosts may partially mimic
the early development of the immune system. We would
like to extrapolate the origin of the natural IgM-secreting
cells from the present results. In newborn and young mice,
during the expansion of the immune system and when the
mature B cells are scarce, the percentage of activated B
lymphocytes is increased (29). In the adult mouse, a pro-
portion of the natural IgM antibodies may be produced by
plasma cells derived from a pool of activated B cells selected
early during ontogeny which resist replacement (30). Sub-
stitution of the initially selected population may be
achieved by cellular competition based on B cell receptor
diversity and antigenic environment (9, 11, 31). Thus, as
observed here, a population of BM-derived B cells would
be more likely to enter the pool of IgM-secreting cells than
a second population of LN B cells expressing a less diverse
repertoire. Studies using Tg animals clearly show that al-
though Tg B cells are in excess and are the first to be pro-
duced, most of the circulating IgMs originate from the
more diverse endogenous cell pool (32, 33). The immune
system seems to be organized to ensure several alternative
sources for the production of the natural antibodies which327 Agenès and Freitas
constitute the first barrier of protection. Every newly
formed B cell has the ability to differentiate into a plasma
cell, but this process is dependent on the nature and the
number of cells already present at the periphery. We pro-
pose that early during the development and expansion of
the immune system an initial pool of activated B cells is se-
lected, which can eventually be competed out by new
specificities formed in the BM (34).
It has also been suggested that B1 B cells are the source
of natural IgMs (35). The present findings may be inter-
preted to suggest that natural IgM production cannot be at-
tributed solely to peritoneal cavity B1 B cells. The trans-
ferred LN B cells were CD52 and remained CD52 during
the expansion phase and at the plateau. In absence of the
B1 cells, other B cell populations might be called to exert
similar functions. The fact that injected B2 LN B cells ac-
quire a B1b phenotype (36), and migrate first to the spleen
and not to the host’s LN, shows that these B cells were not
irreversibly committed to a particular B cell subset, but that
they can undergo a process of adaptive differentiation and
ecological succession. We also know that the selection of
the persisting B cells and the production of the IgM anti-
bodies are T cell independent, since identical results were
obtained in alymphopenic Rag2-deficient mice injected
with LN B cells from CD3e-deficient donors.
Can an established B cell population alter the fate of re-
cent new B cell migrants at the periphery? The answer is
yes. As it has been shown that the rates of BM B cell pro-
duction are not modified by the size of the peripheral B cell
pools (7, 8), the finding of a reduced number of BM-
derived B cells in chimeras hosting an increased number of
resident long-lived B cells from bcl2 Tg donors suggests
that the entry of B cells into the peripheral B cell compart-
ments may be conditioned by the number of established B
cells. We also demonstrate that in the presence of an estab-
lished population of activated B cells there is a diminution
in IgM production by a subsequently introduced B cell
population. These findings indicate that there are mecha-
nisms of feedback regulation controlling terminal B cell
differentiation which could explain former results on allo-
type suppression (37) and on B1 cell development (38, 39).
Feedback regulation could be exerted at the level of termi-
nal B cell differentiation and/or B cell proliferation. The
similar rate of growth of the second transferred LN B cell
population in the absence or the presence of resident B cells
(not shown) suggests that it might operate mainly at the
level of differentiation. Nevertheless, a complete study of
the rate of B cell proliferation in the different experimental
conditions is required. Feedback regulation may be also ex-
erted either through direct suppression of new cell subsets,
or indirectly, by the preconsumption of common resources
necessary for the growth and/or the differentiation of the B
cells (40). In the latter case we must assume that the highly
selected resident B cells will be more efficient in the usage
of the common resources. The different possible mecha-
nisms and the role of the final IgM product in feedback
regulation are currently under investigation.
We have a final comment on the constitutive expression
of IL-10 mRNA by the activated B cells. This lymphokine
downregulates the expression of costimulatory molecules in
antigen-presenting cells and affects T cell proliferation by
blocking both IL-2Ra expression and IL-2 production
(41–43). Activated B cells may have major regulatory func-
tions by preventing inflammation and inducing a Th2 im-
mune response and IgG1 production in their close mi-
croenvironment.
In conclusion, we show that B cells remaining after 2 wk
of transfer in immunodeficient hosts represent a stable B cell
population which persists for prolonged periods of time by
self-renewing, resists replacement, and can modify the fate
of newly arriving B cells. The present findings, which have
profound implications in the mechanisms controlling the
origin of the IgM-secreting cells, suggest that the priority of
the immune system is the production of circulating IgM
levels to ensure a first barrier of protection against infection
and that once a particular B cell is selected it is kept by the
system. Thus, peripheral B cell selection into the activated B
cell compartment follows the rule first come, first served.
We would like to thank Drs. B. Rocha, R. Torres, J. Andersson, and E. Palmer for reviewing this manu-
script; Drs. B. Malissen, A. Rolink, and T. Ternynck for the gift of mice and reagents; A. Louise for sorting;
and N. Legrand for helpful collaboration.
This study was supported by grants from the Agence National de Recherche sur le SIDA and the Association
de Recherche contre le Cancer, France. F. Agenès is supported by a bourse Roux from the Institut Pasteur.
Address correspondence to Fabien Agenès, Laboratoire des Dynamiques Lymphocytaires, CNRS
URA1961, Institut Pasteur, 25-28 rue du Dr. Roux, 75724 Paris cedex 15, France. Phone: 33-1-45-68-85-
82; Fax: 33-1-45-68-86-39; E-mail: fagenes@pasteur.fr
For additional information, please see http://www.pasteur.fr/units/Dynlym/Welcome.html
Received for publication 1 September 1998 and in revised form 29 October 1998.
References
1. Freitas, A.A., B. Rocha, and A. Coutinho. 1986. Lymphocyte
population kinetics in the mouse. Immunol. Rev. 91:5–37.
2. Opstelten, D., and D.G. Osmond. 1983. Pre-B cells in
mouse bone marrow: immunofluorescence stathmokinetic
studies of the proliferation of cytoplasmic mu chain–bearing
cells in normal mice. J. Immunol. 131:2635–2640.328 Homeostasis of Activated B Cells
3. Osmond, D.G. 1986. Population dynamics of bone marrow
B lymphocytes. Immunol. Rev. 93:103–124.
4. Forster, I., P. Vieira, and K. Rajewsky. 1989. Flow cytomet-
ric analysis of cell proliferation dynamics in the B cell com-
partment of the mouse. Int. Immunol. 1:321–331.
5. Rocha, B., C. Penit, C. Baron, F. Vasseur, N. Dautigny, and
A.A. Freitas. 1990. Accumulation of bromodeoxyuridine-
labeled cells in central and peripheral lymphoid organs: mini-
mal estimates of production and turnover rates of mature
lymphocytes. Eur. J. Immunol. 20:1697–1708.
6. Osmond, D.G. 1993. The turnover of B-cell populations.
Immunol. Today. 14:34–37.
7. Agenès, F., M.M. Rosado, and A.A. Freitas. 1997. Indepen-
dent homeostatic regulation of B cell compartments. Eur. J.
Immunol. 27:1801–1807.
8. Lentz, V.M., M.P. Cancro, F.E. Nashold, and C.E. Hayes.
1996. Bcmd governs recruitment of new B cells into the sta-
ble peripheral B cell pool in the A/WySnJ mouse. J. Immu-
nol. 157:598–606.
9. Freitas, A.A., M. Rosado, A.-C. Viale, and A. Grandien.
1995. The role of cellular competition in B cell survival and
selection of B cell repertoires. Eur. J. Immunol. 25:1729–
1738.
10. Thomas-Vaslin, V., and A.A. Freitas. 1989. Lymphocyte
population kinetics during the development of the immune
system. B cell persistence and life span can be determined by
the host environment. Int. Immunol. 1:237–246.
11. Cyster, J.G., and C.C. Goodnow. 1995. Antigen-induced
exclusion from follicles and anergy are separate and comple-
mentary processes that influence peripheral B cell fate. Immu-
nity. 3:691–701.
12. Rusconi, S., and G. Kohler. 1985. Transmission and expres-
sion of a specific pair of rearranged immunoglobulin m and k
genes in a transgenic mouse line. Nature. 314:330–334.
13. Goodnow, C.C., J. Crosbie, S. Adelstein, T.B. Lavoie, S.J.
Smith-Gill, R.A. Brink, H. Pritchard-Briscoe, J.S. Wother-
spoon, R.H. Lablay, K. Raphael, et al. 1988. Altered immu-
noglobulin expression and functional silencing of self-reactive
B lymphocytes in transgenic mice. Nature. 334:676–682.
14. Kitamura, D., J. Roes, R. Kühn, and K. Rajewsky. 1991. A
B-cell deficient mouse by targeted disruption of the mem-
brane exon of the immunoglobulin m chain gene. Nature.
350:423–426.
15. Shinkai, Y., G. Rathbun, K.-P. Lam, E.M. Oltz, V. Stewart,
M. Mendensohn, J. Charron, M. Datta, F. Young, A.M.
Stall, and F.W. Alt. 1992. RAG-2–deficient mice lack ma-
ture lymphocytes owing to inability to initiate V(D)J rear-
rangement. Cell. 68:855–867.
16. Malissen, M., A. Gillet, L. Ardouin, G. Bouvier, J. Trucy, P.
Ferrier, E. Vivier, and B. Malissen. 1995. Altered T cell devel-
opment in mice with a targeted mutation of the CD3-epsilon
gene. EMBO (Eur. Mol. Biol. Organ.) J. 14:4641–4653.
17. Strasser, A., S. Whittingham, D.L. Vaux, M.L. Bath, J.M.
Adams, S. Cory, and A.W. Harris. 1991. Enforced BCL2 ex-
pression in B-lymphoid cells prolongs antibody responses and
elicits autoimmune disease. Proc. Natl. Acad. Sci. USA. 88:
8661–8665.
18. Delassus, S., G.C. Coutinho, C. Saucier, S. Darche, and P.
Kourlisky. 1994. Differential cytokine expression in maternal
blood and placenta during murine gestation. J. Immunol. 152:
2411–2420.
19. Rathmell, J.C., M.P. Cooke, W.Y. Ho, J. Grein, S.E.
Townsend, M.M. Davis, and C.C. Goodnow. 1995. CD95
(Fas)-dependent elimination of self-reactive B cells upon in-
teraction with CD41 T cells. Nature. 376:181–183.
20. Oliver, A.M., F. Martin, G.L. Gartland, R.H. Carter, and
J.F. Kearney. 1997. Marginal zone B cells exhibit unique ac-
tivation, proliferative and immunoglobulin secretory re-
sponses.  Eur. J. Immunol. 27:2366–2374.
21. Kitamura, D., A. Kudo, S. Schaal, W. Muller, F. Melchers,
and K. Rajewsky. 1992. A critical role of lambda 5 protein in
B cell development. Cell. 69:823–831.
22. McDonnell, T.J., N. Deane, F.M. Platt, G. Nunez, U. Jae-
ger, J.P. McKearn, and S.J. Korsmeyer. 1989. bcl-2-Immu-
noglobulin transgenic mice demonstrate extended B cell sur-
vival and follicular lymphoproliferation. Cell. 57:79–88.
23. Freitas, A.A., and B.A. Rocha. 1993. Lymphocyte lifespans:
homeostasis, selection and competition. Immunol. Today. 14:
25–29.
24. Freitas, A.A., and M. De Sousa. 1975. Control mechanisms
of lymphocyte traffic. Modification of the traffic of 51Cr la-
beled mouse lymph node cells by treatment with plant lectins
in intact and splenectomized hosts. Eur. J. Immunol. 5:831.
25. Sprent, J., M. Schaefer, M. Hurd, C.D. Surh, and Y. Ron.
1991. Mature murine B and T cells transferred to SCID mice
can survive indefinitely and many maintain a virgin pheno-
type. J. Exp. Med. 174:717–728.
26. Lepault, F., M.-C. Gagnerault, C. Faveeuw, and C. Boitard.
1994. Recirculation, phenotype and functions of lympho-
cytes in mice treated with monoclonal antibody MEL-14.
Eur. J. Immunol. 24:3106–3112.
27. Lane, P.J., D. Gray, S. Oldfield, and I.C. MacLennan. 1986.
Differences in the recruitment of virgin B cells into antibody
responses to thymus-dependent and thymus-independent
type-2 antigens. Eur. J. Immunol. 16:1569–1575.
28. Klinman, N.R. 1994. Selection in the expression of func-
tionally distinct B-cell subsets. Curr. Opin. Immunol. 6:420–
424.
29. Forni, L., C. Heusser, and A. Coutinho. 1988. Natural lym-
phocyte activation in postnatal development of germ-free
and conventional mice. Ann. Inst. Pasteur Immunol. 139:245–
256.
30. Hamilton, A.M., and J.F. Kearney. 1994. Effects of IgM allo-
type suppression on serum IgM levels, B-1 and B-2 cells, and
antibody responses in allotype heterozygous F1 mice. Dev.
Immunol. 4:27–41.
31. Fulcher, D.A., and A. Basten. 1994. Reduced life-span of an-
ergic self-reactive B cells in a double-transgenic model. J.
Exp. Med. 179:125–134.
32. Grandien, A., A. Coutinho, and J. Anderson. 1990. Selective
peripheral expansion and activation of B cells expressing en-
dogenous immunoglobulin in mu-transgenic mice. Eur. J.
Immunol. 20:991–998.
33. Cascalho, M., A. Ma, S. Lee, L. Masat, and M. Wabl. 1996.
A quasi-monoclonal mouse. Science. 272:1649–1652.
34. Viale, A.-C., A.A. Freitas, and A. Coutinho. 1994. Regula-
tion of VH-gene expression is a lineage-specific develop-
mental marker. Eur. J. Immunol. 24:1353–1358.
35. Riggs, J.E., R.S. Stowers, and D.E. Mosier. 1990. The im-
munoglobulin allotype contributed by peritoneal cavity B
cells dominates in SCID mice reconstituted with allotype-
disparate mixtures of splenic and peritoneal cavity B cells. J.
Exp. Med. 172:475–485.
36. Herzenberg, L.A., and A.B. Kantor. 1993. B-cell lineages
exit in the mouse. Immunol. Today. 14:79–84.
37. Mage, R.G. 1975. Allotype suppression in rabbits: effects of329 Agenès and Freitas
anti-allotype antisera upon expression of immunoglobulin
genes.  Transplant. Rev. 27:84–99.
38. Lalor, P.A., L.A. Herzenberg, S. Adams, and A.M. Stall.
1989. Feedback regulation of murine Ly-1 B cell develop-
ment. Eur. J. Immunol. 19:507–513.
39. Boes, M., C. Esau, M.B. Fischer, T. Schmidt, M. Carroll,
and J. Chen. 1998. Enhanced B-1 cell development, but im-
paired IgG antibody responses in mice deficient in secreted
IgM. J. Immunol. 160:4776–4787.
40. McLean, A., M.M. Rosado, F. Agenès, R. Vasconcelos, and
A.A. Freitas. 1997. Resource competition as a mechanism for
B cell homeostasis. Proc. Natl. Acad. Sci. USA. 94:5792–
5797.
41. Ding, L., P.S. Linsley, L.Y. Huang, R.N. Germain, and E.M.
Shevach. 1993. IL-10 inhibits macrophage costimulatory ac-
tivity by selectively inhibiting the up-regulation of B7 ex-
pression. J. Immunol. 151:1224–1234.
42. Macatonia, S.E., T.M. Doherty, S.C. Knight, and A.
O’Garra. 1993. Differential effect of IL-10 on dendritic cell–
induced T cell proliferation and IFN-gamma production. J.
Immunol. 150:3755–3765.
43. Taga, K., H. Mostowski, and G. Tosato. 1993. Human inter-
leukin-10 can directly inhibit T-cell growth. Blood. 81:2964–
2971.